Back
ACNAP Premium Access

Can we use HbA1c as a biomarker for predicting the short-term outcome after acute myocardial infarction?

Session: Poster Session 2 - Acute Coronary Syndromes - Treatment
Topic: Pharmacotherapy
Speaker: Doctor M. El Tahlawi (Zagazig, EG)
Event: EuroHeartCare 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Mohammad El Tahlawi

Zagazig University Hospitals, Zagazig (Egypt)
1 presentation
0 follower

6 more presentations in this session

Treatment of acute hyperglycemia: evaluation of a Yale protocol adapted for patients with acute coronary syndrome (YALE-ACS)

Speaker: Mr M. Mazza (Milan, IT)

Access
Abstract
Slides
Like
Thumbnail

Coronary artery ectasia, an independent predictor of high thrombus burden in patients presenting with ST-elevation myocardial infarction

Speaker: Mr K. Kintis (Athens, GR)

Access
Like
Thumbnail

Thrombus aspiration in combination with glycoprotein IIb/IIIa inhibitors with or without stent implantation in patients presenting with STEMI and high thrombus burden

Speaker: Mr K. Kintis (Athens, GR)

Access
Like
Thumbnail

Patients experiences with generic drugs following early post-discharge after first-time percutaneous coronary intervention

Speaker: Professor T. Norekval (Bergen, NO)

Access
Abstract
Like
Thumbnail

Llong-term natural course and clinical outcomes of coronary spasm

Speaker: Doctor M. Lee (Seoul, KR)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 2 - Acute Coronary Syndromes - Treatment

Speakers: Doctor M. El Tahlawi, Mr M. Mazza, Mr K. Kintis, Mr K. Kintis, Professor T. Norekval...
Access
Like
Thumbnail

About the event

Image

EuroHeartCare 2019

2 May - 4 May 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources